1. Home
  2. LIDR vs SLGL Comparison

LIDR vs SLGL Comparison

Compare LIDR & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc.

LIDR

AEye Inc.

HOLD

Current Price

$2.19

Market Cap

118.0M

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$53.24

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDR
SLGL
Founded
2013
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
117.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
LIDR
SLGL
Price
$2.19
$53.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$50.00
AVG Volume (30 Days)
1.4M
18.9K
Earning Date
02-19-2026
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$182,000.00
$18,970,000.00
Revenue This Year
$2.76
$121.82
Revenue Next Year
$2,830.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
62.04
52 Week Low
$0.49
$4.02
52 Week High
$6.44
$52.26

Technical Indicators

Market Signals
Indicator
LIDR
SLGL
Relative Strength Index (RSI) 47.60 71.05
Support Level $2.09 $40.10
Resistance Level $2.32 $44.99
Average True Range (ATR) 0.13 3.02
MACD 0.00 0.51
Stochastic Oscillator 61.61 81.93

Price Performance

Historical Comparison
LIDR
SLGL

About LIDR AEye Inc.

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: